Concepedia

Danilo Maddalo

DM

13

Publications

1.4K

Citations

12

H-Index

2010

Active since

Affiliations

Karlsruhe Institute of Technology(Current)

Memorial Sloan Kettering Cancer Center

New York University

Novartis (Switzerland)

Innsbruck Medical University

Danilo Maddalo is an author at Karlsruhe Institute of Technology specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

2010–2025

13

Publications

13

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

Danilo Maddalo, Eusebio Manchado, Carla P. Concepcion et al. · Nature · 2014 · 649 citations · Full text

, , +9

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance

Thijs J. Hagenbeek, Marc Hafner, Rana Mroue et al. · Nature Cancer · 2023 · 169 citations · Full text

The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment

Corinna Roller, Danilo Maddalo · Frontiers in Pharmacology · 2013 · 135 citations · Full text

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection

Huajie Bu, Stefanie Bormann, Georg Schäfer et al. · The Prostate · 2010 · 113 citations

Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis

Anja Bruchmann, Corinna Roller, Tamara Vanessa Walther et al. · BMC Cancer · 2013 · 75 citations · Full text

Rows per page

1–5 of 13